When did PACIFIC BIOSCIENCES OF CALIF (PACB) report earnings last quarter?
PACIFIC BIOSCIENCES OF CALIF (PACB) last reported earnings on 2/12/2026.
PACIFIC BIOSCIENCES OF CALIF (PACB) Earnings History & Surprises
NASDAQ:PACB • US69404D1081
Current stock price
1.4 USD
+0.07 (+5.26%)
Last:
PACB Earnings overview
Past quarterly earnings results for PACIFIC BIOSCIENCES OF CALIF (PACB), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Apr 7, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.14
- Revenue Estimate
- 40.753M
Last Reported
Most Recent- Release Date
- Feb 12, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.12
- EPS Surprise
- 20.24%
- Revenue Surprise
- 2.91%
Beat Rate
Last 8 Quarters 44%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.12 | -0.15 | 20.24% | 75.51% | 44.645M | 43.381M | 2.91% | 13.82% |
| Q3 2025 | -0.13 | -0.16 | 16.15% | 40.91% | 38.441M | 41.014M | -6.27% | -3.82% |
| Q2 2025 | -0.14 | -0.17 | 19.26% | 78.13% | 39.766M | 37.658M | 5.60% | 10.42% |
| Q1 2025 | -1.44 | -0.19 | -646.97% | -396.55% | 37.153M | 35.947M | 3.35% | -4.27% |
| Q4 2024 | -0.49 | -0.21 | -133.89% | -58.06% | 39.224M | 40.964M | -4.25% | -32.79% |
| Q3 2024 | -0.22 | -0.23 | 3.93% | 15.38% | 39.967M | 42.794M | -6.61% | -28.23% |
| Q2 2024 | -0.64 | -0.24 | -169.73% | -128.57% | 36.013M | 41.695M | -13.63% | -24.30% |
| Q1 2024 | -0.29 | -0.28 | -3.24% | 19.44% | 38.81M | 43.821M | -11.44% | -0.23% |
| Q4 2023 | -0.31 | -0.29 | -6.56% | 16.22% | 58.357M | 58.635M | -0.47% | 113.37% |
| Q3 2023 | -0.26 | -0.33 | 22.31% | 23.53% | 55.691M | 49.736M | 11.97% | 72.36% |
| Q2 2023 | -0.28 | -0.33 | 14.39% | 12.50% | 47.573M | 41.104M | 15.74% | 34.12% |
| Q1 2023 | -0.36 | -0.34 | -6.15% | 2.70% | 38.9M | 35.071M | 10.92% | 17.27% |
| Q4 2022 | -0.37 | -0.37 | -0.41% | -19.35% | 27.35M | 26.762M | 2.20% | -24.07% |
| Q3 2022 | -0.34 | -0.34 | -0.50% | -47.83% | 32.31M | 36.108M | -10.52% | -7.39% |
| Q2 2022 | -0.32 | -0.33 | 2.97% | -52.38% | 35.47M | 35.863M | -1.10% | 15.88% |
| Q1 2022 | -0.37 | -0.31 | -17.65% | 17.78% | 33.17M | 33.476M | -0.91% | 14.38% |
| Q4 2021 | -0.31 | -0.29 | -7.27% | -183.78% | 36.02M | 36.842M | -2.23% | 32.72% |
| Q3 2021 | -0.23 | -0.22 | -3.67% | -64.29% | 34.89M | 33.898M | 2.93% | 82.86% |
| Q2 2021 | -0.21 | -0.21 | 0.06% | -40.00% | 30.61M | 30.589M | 0.07% | 79.22% |
| Q1 2021 | -0.45 | -0.47 | 3.67% | -114.29% | 29M | 26.093M | 11.14% | 85.90% |
| Q4 2020 | 0.37 | 0.32 | 14.07% | - | 27.14M | 25.92M | 4.71% | - |
| Q3 2020 | -0.14 | -0.14 | -2.43% | - | 19.08M | 20.758M | -8.08% | - |
| Q2 2020 | -0.15 | -0.18 | 18.30% | - | 17.08M | 13.997M | 22.03% | - |
| Q1 2020 | -0.21 | -0.16 | -30.72% | - | 15.6M | 20.47M | -23.79% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
-147.83%
Max EPS beat (4)
20.24%
Min EPS beat (4)
-646.97%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
1.40%
Max Revenue beat (4)
5.60%
Min Revenue beat (4)
-6.27%
Analysis
In the last 4 quarters, PACB has beaten EPS estimates in 3 out of 4 releases
PACB has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, PACB reported -147.8% below the EPS estimates on average.
In the last 4 quarters, PACB has beaten the revenue estimates by 1.4% on average.
Related analysis
PACIFIC BIOSCIENCES OF CALIF / PACB Earnings FAQ
Can you provide information on whether PACIFIC BIOSCIENCES OF CALIF beat earnings estimates in the last quarter?
PACIFIC BIOSCIENCES OF CALIF (PACB) beat EPS estimates and beat revenue estimates in the most recent quarter.
How often does PACIFIC BIOSCIENCES OF CALIF (PACB) beat earnings estimates?
In the last 4 quarters, PACIFIC BIOSCIENCES OF CALIF (PACB) has beaten EPS estimates in 3 out of 4 releases.